Cell and Gene Therapy

TDP-43 aggregation drives loss of UNC13A, a risk gene for ALS & FTD 3:27
TDP-43 aggregation drives loss of UNC13A, a risk gene for ALS & FTD
Matthew Keuss • 17 Mar 2023
Viral-mediated gene therapy for neurodegenerative disease 5:00
Viral-mediated gene therapy for neurodegenerative disease
Boris Kantor • 29 Jul 2022
Improving the precision and safety of CRISPR/Cas genome editing 3:39
Improving the precision and safety of CRISPR/Cas genome editing
Boris Kantor • 29 Jul 2022
Developing APOE-targeted epigenome therapy for the treatment of Alzheimer’s disease 5:02
Developing APOE-targeted epigenome therapy for the treatment of Alzheimer’s disease
Boris Kantor • 29 Jul 2022
The content of VJDementia is intended for healthcare professionals